Relpax and Tacrolimus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Relpax (eletriptan hydrobromide) and Tacrolimus (tacrolimus). Common drug interactions include malaise among females.

The phase IV clinical study analyzes what interactions people have when they take Relpax and Tacrolimus. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Relpax?

Relpax has active ingredients of eletriptan hydrobromide. It is often used in migraine. eHealthMe is studying from 9,259 Relpax users. Check the latest studies of Relpax.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.

On Jul, 12, 2026

19 people who take Relpax and Tacrolimus together, and have interactions are studied.

Relpax and Tacrolimus drug interactions.

What are the common drug interactions of Relpax and Tacrolimus, by gender? *:

female:

Malaise (a feeling of general discomfort or uneasiness)
Pain
Gastroenteritis (inflammation of stomach and intestine)
Hyperuricaemia (level of uric acid in the blood that is abnormally high)
Iron deficiency anaemia
Nausea (feeling of having an urge to vomit)
Osteonecrosis (death of bone)
Pulmonary embolism (blockage of the main artery of the lung)
Upper respiratory tract inflammation
Activities of daily living impaired

male:

n/a

What are the common drug interactions of Relpax and Tacrolimus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Arthralgia (joint pain)
Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Gastroenteritis (inflammation of stomach and intestine)
Hyperuricaemia (level of uric acid in the blood that is abnormally high)
Iron deficiency anaemia
Osteonecrosis (death of bone)
Pulmonary embolism (blockage of the main artery of the lung)
Upper respiratory tract inflammation
Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)

30-39:

n/a

40-49:

n/a

50-59:

Activities of daily living impaired
Psoriasis (immune-mediated disease that affects the skin)
Disease progression
Drug intolerance (drug sensitivity)
Eating disorder
Malaise (a feeling of general discomfort or uneasiness)
Nausea (feeling of having an urge to vomit)
Pain
Retching (strong involuntary effort to vomit)
Vomiting

60+:

Fall
Hip fracture

What are the existing conditions these people have? *

Upper Respiratory Tract Inflammation: 9 people, 47.37%
Iron Deficiency Anaemia: 9 people, 47.37%
Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 9 people, 47.37%
Constipation: 9 people, 47.37%
Diabetes: 9 people, 47.37%
Gastroenteritis (inflammation of stomach and intestine): 9 people, 47.37%
Pulmonary Embolism (blockage of the main artery of the lung): 9 people, 47.37%
Hyperlipidaemia (presence of excess lipids in the blood): 9 people, 47.37%
Joint Pain: 9 people, 47.37%
Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 9 people, 47.37%

* Approximation only. Some reports may have incomplete information.

Do you take Relpax and Tacrolimus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously